In a study published in Blood in 2006, Prabhala et al. [82] used CD4+Foxp3+ gating to detect the proportion of Tregs in PBMC from healthy people, MGUS and MM patients, and evaluated their ability to inhibit T cell proliferation. This evidence concerns the gene FOXP3 and Miyoshi myopathy.